Skip to main content
Balaji Amines Ltd. logo

Balaji Amines Ltd. — Investor Relations & Filings

Ticker · BALAMINES ISIN · INE050E01027 LEI · 3358009DS8RG4Z8QBD69 BSE.NS Manufacturing
Filings indexed 741 across all filing types
Latest filing 2026-03-28 Regulatory Filings
Country IN India
Listing BSE.NS BALAMINES

About Balaji Amines Ltd.

https://www.balajiamines.com/

Balaji Amines Ltd. is a leading manufacturer specializing in Aliphatic Amines, their derivatives, and specialty chemicals. The company produces a diverse range of products, including Methylamines, Ethylamines, and specialty chemicals such as N-Methyl-2-Pyrrolidone (NMP), Morpholine, Dimethylformamide (DMF), and Gamma-Butyrolactone (GBL). Its portfolio serves critical sectors including pharmaceuticals, agrochemicals, refineries, water treatment, and personal care. Utilizing advanced manufacturing technologies and vertically integrated processes, the company maintains a significant market presence in the production of amines and downstream derivatives. Balaji Amines is recognized for its large-scale production capacity and its role as a key supplier of essential chemical intermediates used in the synthesis of active pharmaceutical ingredients and crop protection chemicals.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window pursuant to SEBI regulations ahead of the announcement of audited financial results for the quarter and year ended 31st March 2026. It does not contain any financial data or results itself, nor does it announce the results. It is an announcement related to compliance and insider trading restrictions before the financial results are declared. The document length is short (1843 characters) and it serves as a regulatory notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS).
2026-03-28 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stock exchanges about operational disruptions due to supply chain issues caused by external geopolitical events. It is a regulatory announcement about a material event affecting the company but does not contain financial statements, detailed financial data, or a report itself. The document is relatively short (2347 characters) and serves as a notification to the exchanges rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not fit other specific categories.
2026-03-12 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges about the cancellation of a scheduled plant visit and management meet with investors/analysts. It is dated March 9, 2026, and references a previous intimation dated February 27, 2026. The content is an announcement of a change in event scheduling rather than a report or detailed financial disclosure. The document length is only 1315 characters, indicating it is a brief announcement. There is no financial data, no management discussion, no voting results, no regulatory certification, or any other detailed report content. Therefore, it fits best as a Regulatory Filing (RNS), which is a general category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-03-09 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement disclosure under SEBI Listing Regulations. It mentions the publication of a special window for transfer and dematerialisation of physical shares. The document is short (1392 characters) and serves as a notification or announcement rather than a detailed report or financial statement. It does not contain financial data, management discussion, or regulatory certifications. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement related to compliance and disclosure requirements under SEBI regulations.
2026-03-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the schedule of analyst and institutional investor meetings, specifically a plant visit and management meet. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, particularly Regulation 30(6), which pertains to disclosure of material events. The document explicitly states that discussions will be based on publicly available information and no unpublished price sensitive information will be disclosed. It also mentions that the latest investor presentation is available on the company's website, but this document itself is not the presentation. The document is short (1996 characters) and serves as an announcement or intimation rather than a detailed report or transcript. It does not contain financial data, earnings, or detailed management discussion. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-27 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It mentions the publication of newspaper advertisements containing extracts of standalone and consolidated unaudited financial results for the quarter and nine months ended 31st December 2025. The document itself does not contain the full financial results or detailed financial statements but refers to the publication of extracts in newspapers. The document length is short (1390 characters), and it serves as a notification or announcement of the financial results publication rather than the full report. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement and compliance communication rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2026-01-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.